Xiangying Kong

No. 300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Discovery of Highly Potent Phthalazinone Derivatives as PARP14 Inhibitors: From Structure-Based Virtual Screening to In Vivo Pharmacodynamic Activity.

Discovery of Highly Potent Phthalazinone Derivatives as PARP14 Inhibitors: From Structure-Based Virtual Screening to In Vivo Pharmacodynamic Activity.

Journal: Journal of medicinal chemistry
Published: April 20, 2026

YiJing Powder activates the HO-1/NRF2/KEAP1 antioxidant axis to remodel lipid metabolism and ameliorate oligoasthenospermia.

YiJing Powder activates the HO-1/NRF2/KEAP1 antioxidant axis to remodel lipid metabolism and ameliorate oligoasthenospermia.

Journal: Journal of ethnopharmacology
Published: August 22, 2025

Discovery of Orally Potent Small-Molecule CD73 Inhibitor for Cancer Immunotherapy.

Discovery of Orally Potent Small-Molecule CD73 Inhibitor for Cancer Immunotherapy.

Journal: Journal of medicinal chemistry
Published: May 23, 2025

Discovery of novel JAK3 inhibitors for the treatment of atopic dermatitis.

Discovery of novel JAK3 inhibitors for the treatment of atopic dermatitis.

Journal: Bioorganic & medicinal chemistry letters
Published: January 02, 2025

An evaluation of a five-year program for newborn congenital heart disease screening in Jiangsu Province, 2019-2023.

An evaluation of a five-year program for newborn congenital heart disease screening in Jiangsu Province, 2019-2023.

Journal: BMC public health
Published: August 08, 2024

Identification of novel antifreeze peptides from yak skin gelatin ultrasound-assisted enzymatic hydrolysate.

Identification of novel antifreeze peptides from yak skin gelatin ultrasound-assisted enzymatic hydrolysate.

Journal: Ultrasonics sonochemistry
Published: August 02, 2024

Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression.

Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression.

Journal: Journal of medicinal chemistry
Published: March 13, 2024

Blood ethylene oxide, systemic inflammation, and serum lipid profiles: Results from NHANES 2013-2016.

Blood ethylene oxide, systemic inflammation, and serum lipid profiles: Results from NHANES 2013-2016.

Journal: Chemosphere
Published: December 08, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026